Annelise Bennaceur

Company: iPSirius

Job title: Chief Scientific Officer

Seminars:

Roundtable Discussion: Identifying Factors Contributing to iPSC Genomic Instability 2:30 pm

Identifying factors that contribute to genomic instability in iPSCs and their impact on therapeutic outcomes Developing novel techniques to identify genomic instability at the level of iPSCs and derived cells Exploring strategies to mitigate genomic instability, including optimized reprogramming techniques and targeted genetic modificationsRead more

day: Day One Track A Afternoon

Balancing Quality, Consistency & Scalability of Starting Cell Lines through Strategic Selection 9:10 am

Choosing the right iPSC starting line is fundamental to influencing safety, efficacy, and manufacturability. Key factors such as donor selection, genomic stability, and differentiation potential must be carefully evaluated alongside evolving regulatory expectations. This session will explore best practices for optimizing cell line selection, balancing standardization with therapy-specific requirements.Read more

day: Pre-Conference Workshop Day